catalog number :
MBS691906
products type :
Recombinant Protein
products full name :
Recombinant Mouse FGF-23
products short name :
[FGF-23]
products name syn :
[Fibroblast Growth Factor 23]
other names :
[fibroblast growth factor 23; Fibroblast growth factor 23; fibroblast growth factor 23; FGF-23; fibroblast growth factor 23]
products gene name :
[FGF-23]
other gene names :
[Fgf23; Fgf23; FGF-23]
uniprot entry name :
FGF23_MOUSE
sequence :
MYPDTSPLLG SNWGSLTHLY TATARTSYHL QIHRDGHVDG TPHQTI YSAL MITSEDAGSV VITGAMTRRF LCMDLHGNIF GSLHFSPENC K FRQWTLENG YDVYLSQKHH YLVSLGRAKR IFQPGTNPPP FSQFLAR RNE VPLLHFYTVR PRRHTRSAED PPERDPLNVL KPRPRATPVP VS CSRELPSA EEGGPAASDP LGVLRRGRGD ARGGAGGADR CRPFPRFV
purity :
> 95% by SDS-PAGE & HPLC analyses
storage stability :
The lyophilized protein is stable at room temperature for 1 month and at 4°C for 6 months. Reconstituted working aliquots are stable for 1 week at 2°C to 8°C and for 3 months at -20°C to -80°C.
other info1 :
Expressed in: E.coli. Biological Activity: Determined by its ability to stimulate the proliferation of murine NIH-3T3 cells. The expected ED 50 for this effect is 0.3-0.5 ug/ml, in the presence of murine Klotho and heparin. Endotoxin Level: < 0.1 ng/ug of protein (<1EU/ug)
other info2 :
Reconstitution: Centriguge the vial before opening. Reconstitute in water to a concentration of 0.1-1.0 mg/m. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it recommended to further dilute in a buffer containing a carrier protein (example: 0.1% BSA) and store in working aliquots at -20°C to -80°C.
products categories :
Cytokines & Growth Factors
products description :
The FGF family plays a central role during prenatal development and postnatal growth, and the regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-23, FGF-21 and FGF-19 constitute an atypical FGF subfamily whose ligands act as circulating hormones and require the participation of a Klotho protein as a co-receptor for their signaling. FGF-23 is a bone-derived hormone that acts in the kidney to regulate phosphate homeostasis and vitamin D metabolism. The signaling receptor for FGF-23, a Klotho-FGFR1 (IIIc) complex, is an essential regulator of the renal sodium phosphate co-transporter and key vitamin D-metabolizing enzymes CYP27B1 and CYP24A1. Recombinant murine FGF-23 is a 25.5 kDa globular protein containing 228 amino acid residues.
ncbi acc num :
NP_073148.1
ncbi gb acc num :
NM_022657.4
ncbi mol weight :
25.5 kDa
ncbi pathways :
Activated Point Mutants Of FGFR2 Pathway (926270); Adaptive Immune System Pathway (926013); Constitutive PI3K/AKT Signaling In Cancer Pathway (926316); DAP12 Interactions Pathway (926127); DAP12 Signaling Pathway (926128); Disease Pathway (926229); Downstream Signaling Events Of B Cell Receptor (BCR) Pathway (926027); Downstream Signal Transduction Pathway (926957); Downstream Signaling Of Activated FGFR Pathway (926257); ESC Pluripotency Pathways (198374)
ncbi summary :
This gene encodes a member of the fibroblast growth factor family. The encoded protein regulates phosphate homeostasis and vitamin D metabolism. Mutation of the related gene in humans causes autosomal dominant hypophosphatemic rickets (ADHR). The secreted protein is further cleaved into N- and C-terminal chains, which results in loss of function. [provided by RefSeq, Mar 2013]
uniprot summary :
Function: Regulator of phosphate homeostasis . By similarity. Inhibits renal tubular phosphate transport by reducing SLC34A1 levels . By similarity. Acts directly on the parathyroid to decrease PTH secretion . By similarity. Regulator of vitamin-D metabolism . By similarity. Negatively regulates osteoblasts differentiation and matrix mineralization . By similarity. Upregulates EGR1 expression in the presence of KL. Ref.3. Subunit structure: Interacts with FGFR1, FGFR2, FGFR3 and FGFR4. Affinity between fibroblast growth factors (FGFs) and their receptors is increased by KL and heparan sulfate glycosaminoglycans that function as coreceptors . By similarity. Ref.3. Subcellular location: Secreted . By similarity. Note: Secretion is dependent on O-glycosylation . By similarity. Tissue specificity: Mainly expressed in the brain and thymus at low levels. In brain; preferentially expressed in the ventrolateral thalamic nucleus. Post-translational modification: Following secretion this protein is inactivated by cleavage into a N-terminal fragment and a C-terminal fragment. The processing is effected by proprotein convertases . By similarity.O-glycosylated by GALT3. Glycosylation is necessary for secretion; it blocks processing by proprotein convertases when the O-glycan is alpha 2,6-sialylated. Competition between proprotein convertase cleavage and block of cleavage by O-glycosylation determines the level of secreted active FGF23 . By similarity. Sequence similarities: Belongs to the heparin-binding growth factors family.